<?xml version='1.0' encoding='UTF-8'?>
<extracted-tables-set><pmcid>6411906</pmcid><all-ids><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmid">30558869</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="pmc">6411906</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">S2213-1582(18)30382-6</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="doi">10.1016/j.nicl.2018.101634</article-id><article-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" pub-id-type="publisher-id">101634</article-id></all-ids><extracted-table><table-id>t0005</table-id><table-label>Table 1</table-label><table-caption>Characteristics of MR procedure (1a) and included samples (1b).</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0005"><label>Table 1</label><caption><p>Characteristics of MR procedure (1a) and included samples (1b).</p></caption><alt-text id="al0025">Table 1</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Table 1a<hr/></th><th colspan="3">MR characteristics<hr/></th><th colspan="5">Functional imaging<hr/></th></tr><tr><th>Sample</th><th>Source</th><th>Scanner/Software</th><th>Anatomical resolution</th><th>Scan duration</th><th>TR (ms)</th><th>TE (ms)</th><th>Flip angle</th><th>Resolution</th></tr></thead><tbody><tr><td>Main ASD</td><td>ABIDE - BNI</td><td>3.0 Tesla Ingenia</td><td>1.11 × 1.11 × 1.20 mm</td><td>369 s</td><td>3000</td><td>25</td><td>80</td><td>3.75 × 3.75 × 4.00 mm</td></tr><tr><td>Control ASD</td><td>ABIDE - IU</td><td>3.0 Tesla Siemens TrioTim</td><td>0.70 × 0.70 × 0.70 mm</td><td>352 s</td><td>813</td><td>28</td><td/><td>3.40 × 3.40 × 3.40 mm</td></tr><tr><td>SCH</td><td>COBRE</td><td>3.0 Tesla Siemens TrioTim</td><td>1.00 × 1.00 × 1.00 mm</td><td>300 s</td><td>2000</td><td>29</td><td>75</td><td>3.80 × 3.80 × 3.50 mm</td></tr><tr><td colspan="9">  </td></tr></tbody></table><table frame="hsides" rules="groups"><thead><tr><th>Table 1b<hr/></th><th colspan="7">Sample characteristics<hr/></th></tr><tr><th>Sample</th><th>Subj (n)</th><th>Subj (n) after motion correction</th><th>Mean Age (y)</th><th>Sex (M)</th><th>IQ</th><th>Medications</th><th>Eyes</th></tr></thead><tbody><tr><td>Main ASD</td><td>29 ASD<break/>29 TYP</td><td>25 ASD<break/>26 TYP</td><td>ASD: 36.54 ± 15.46<break/>TYP: 40.11 ± 15.06</td><td>All</td><td>ASD: 107.11 ± 13.82<break/>TYP: 111.85 ± 12.32 (KBIT2)</td><td>Antidepressant: 8 ASD</td><td>Closed</td></tr><tr><td>Control ASD</td><td>21 ASD<break/>21 TYP</td><td>17 ASD<break/>18 TYP</td><td>ASD: 25.65 ± 9.96<break/>TYP: 24.25 ± 5.27</td><td>All</td><td>ASD: 116.18 ± 12.84<break/>TYP: 116.39 ± 11.04 (WASI-II)</td><td>Information not available</td><td>Open</td></tr><tr><td>SCH</td><td>72 SCH<break/>75 TYP</td><td>41 SCH<break/>55 TYP</td><td>SCH: 38.02 ± 13.54<break/>TYP: 35.53 ± 11.59</td><td>SCH: 32<break/>TYP: 38</td><td>&gt; 80 (inclusion criteria)</td><td>Antipsychotic: 32 SCH</td><td>Open</td></tr></tbody></table><table-wrap-foot><fn><p>Note: ASD = autism; SCH = schizophrenia; TYP = neurotypicals.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="caption">Characteristics of MR procedure (1a) and included samples (1b).</div>Table 1<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Table 1a</th><th colspan="3">MR characteristics</th><th colspan="5">Functional imaging</th></tr><tr><th>Sample</th><th>Source</th><th>Scanner/Software</th><th>Anatomical resolution</th><th>Scan duration</th><th>TR (ms)</th><th>TE (ms)</th><th>Flip angle</th><th>Resolution</th></tr></thead><tbody><tr><td>Main ASD</td><td>ABIDE - BNI</td><td>3.0 Tesla Ingenia</td><td>1.11 × 1.11 × 1.20 mm</td><td>369 s</td><td>3000</td><td>25</td><td>80</td><td>3.75 × 3.75 × 4.00 mm</td></tr><tr><td>Control ASD</td><td>ABIDE - IU</td><td>3.0 Tesla Siemens TrioTim</td><td>0.70 × 0.70 × 0.70 mm</td><td>352 s</td><td>813</td><td>28</td><td/><td>3.40 × 3.40 × 3.40 mm</td></tr><tr><td>SCH</td><td>COBRE</td><td>3.0 Tesla Siemens TrioTim</td><td>1.00 × 1.00 × 1.00 mm</td><td>300 s</td><td>2000</td><td>29</td><td>75</td><td>3.80 × 3.80 × 3.50 mm</td></tr><tr><td colspan="9">  </td></tr></tbody></table></div><div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Table 1b</th><th colspan="7">Sample characteristics</th></tr><tr><th>Sample</th><th>Subj (n)</th><th>Subj (n) after motion correction</th><th>Mean Age (y)</th><th>Sex (M)</th><th>IQ</th><th>Medications</th><th>Eyes</th></tr></thead><tbody><tr><td>Main ASD</td><td>29 ASD29 TYP</td><td>25 ASD26 TYP</td><td>ASD: 36.54 ± 15.46TYP: 40.11 ± 15.06</td><td>All</td><td>ASD: 107.11 ± 13.82TYP: 111.85 ± 12.32 (KBIT2)</td><td>Antidepressant: 8 ASD</td><td>Closed</td></tr><tr><td>Control ASD</td><td>21 ASD21 TYP</td><td>17 ASD18 TYP</td><td>ASD: 25.65 ± 9.96TYP: 24.25 ± 5.27</td><td>All</td><td>ASD: 116.18 ± 12.84TYP: 116.39 ± 11.04 (WASI-II)</td><td>Information not available</td><td>Open</td></tr><tr><td>SCH</td><td>72 SCH75 TYP</td><td>41 SCH55 TYP</td><td>SCH: 38.02 ± 13.54TYP: 35.53 ± 11.59</td><td>SCH: 32TYP: 38</td><td>&gt; 80 (inclusion criteria)</td><td>Antipsychotic: 32 SCH</td><td>Open</td></tr></tbody></table></div>Note: ASD = autism; SCH = schizophrenia; TYP = neurotypicals.</transformed-table></extracted-table><extracted-table><table-id>t0010</table-id><table-label>Table 2</table-label><table-caption>PLE differencies between TYP and ASD with Hamming Window of 3, 7 and 11.</table-caption><original-table><table-wrap xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" position="float" id="t0010"><label>Table 2</label><caption><p>PLE differencies between TYP and ASD with Hamming Window of 3, 7 and 11.</p></caption><alt-text id="al0030">Table 2</alt-text><table frame="hsides" rules="groups"><thead><tr><th>Hamming window</th><th>Network</th><th>Mean PLE ASD</th><th>Mean PLE TYP</th><th>p-Value (Bonferroni corrected)</th></tr></thead><tbody><tr><td rowspan="3">3</td><td>SN</td><td>0.666</td><td>0.506</td><td>0.003<xref rid="tf0005" ref-type="table-fn">⁎⁎</xref></td></tr><tr><td>DMN</td><td>0.669</td><td>0.575</td><td>0.068</td></tr><tr><td>FPTC</td><td>0.678</td><td>0.601</td><td>0.392</td></tr><tr><td rowspan="3">7</td><td>SN</td><td>0.656</td><td>0.504</td><td>0.005<xref rid="tf0005" ref-type="table-fn">⁎⁎</xref></td></tr><tr><td>DMN</td><td>0.667</td><td>0.574</td><td>0.077</td></tr><tr><td>FPTC</td><td>0.670</td><td>0.598</td><td>0.442</td></tr><tr><td rowspan="3">11</td><td>SN</td><td>0.644</td><td>0.496</td><td>0.006<xref rid="tf0005" ref-type="table-fn">⁎⁎</xref></td></tr><tr><td>DMN</td><td>0.663</td><td>0.569</td><td>0.068</td></tr><tr><td>FPTC</td><td>0.661</td><td>0.591</td><td>0.490</td></tr></tbody></table><table-wrap-foot><fn><p>Note: PLE = Power-law Exponent; TYP = neurotypical subjects; ASD = autistic subjects; SN = Salience Network; DMN = Default Mode Network; FPTC = Fronto-Parietal Task Control Network</p></fn></table-wrap-foot><table-wrap-foot><fn id="tf0005"><label>⁎⁎</label><p id="np0005">significant difference between TYP and ASD.</p></fn></table-wrap-foot></table-wrap></original-table><transformed-table>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="caption">PLE differencies between TYP and ASD with Hamming Window of 3, 7 and 11.</div>Table 2<div xmlns="http://www.w3.org/1999/xhtml" class="table"><table frame="hsides" rules="groups"><thead><tr><th>Hamming window</th><th>Network</th><th>Mean PLE ASD</th><th>Mean PLE TYP</th><th>p-Value (Bonferroni corrected)</th></tr></thead><tbody><tr><td rowspan="3">3</td><td>SN</td><td>0.666</td><td>0.506</td><td>0.003???</td></tr><tr><td>DMN</td><td>0.669</td><td>0.575</td><td>0.068</td></tr><tr><td>FPTC</td><td>0.678</td><td>0.601</td><td>0.392</td></tr><tr><td rowspan="3">7</td><td>SN</td><td>0.656</td><td>0.504</td><td>0.005???</td></tr><tr><td>DMN</td><td>0.667</td><td>0.574</td><td>0.077</td></tr><tr><td>FPTC</td><td>0.670</td><td>0.598</td><td>0.442</td></tr><tr><td rowspan="3">11</td><td>SN</td><td>0.644</td><td>0.496</td><td>0.006???</td></tr><tr><td>DMN</td><td>0.663</td><td>0.569</td><td>0.068</td></tr><tr><td>FPTC</td><td>0.661</td><td>0.591</td><td>0.490</td></tr></tbody></table></div>Note: PLE = Power-law Exponent; TYP = neurotypical subjects; ASD = autistic subjects; SN = Salience Network; DMN = Default Mode Network; FPTC = Fronto-Parietal Task Control Network⁎⁎significant difference between TYP and ASD.</transformed-table></extracted-table></extracted-tables-set>